Bristol Myers Squibb (BMY) Deferred Taxes (2009 - 2026)
Bristol Myers Squibb (BMY) reported Deferred Taxes of $161.0 million for Q1 2026, down 27.8% year-over-year from $223.0 million in Q1 2025, and up 141.07% on a QoQ basis from -$392.0 million in Q4 2025.
Bristol Myers Squibb (BMY) has 18 years of Deferred Taxes data on file, last reported at $161.0 million in Q1 2026.
- Quarterly Deferred Taxes fell 27.8% year-over-year to $161.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.0 billion (up 11.08% YoY) and the FY2025 annual result came in at -$965.0 million, up 53.81% from the prior year.
- Deferred Taxes rose to $161.0 million in Q1 2026 per BMY's latest filing, from -$392.0 million in the prior quarter.
- Across five years, Deferred Taxes topped out at $223.0 million in Q1 2025 and bottomed at -$1.3 billion in Q4 2023.
- The 5-year median for Deferred Taxes is -$548.0 million (2023), against an average of -$524.6 million.
- The widest annual swing landed in 2022, when Deferred Taxes slumped 1915.62%; it then soared 131.36% in 2025.
- Tracing BMY's Deferred Taxes over 5 years: stood at -$624.0 million in 2022, then sank by 112.66% to -$1.3 billion in 2023, then jumped by 40.39% to -$791.0 million in 2024, then soared by 50.44% to -$392.0 million in 2025, then soared by 141.07% to $161.0 million in 2026.
- Per Business Quant, the three latest BMY Deferred Taxes figures stand at $161.0 million (Q1 2026), -$392.0 million (Q4 2025), and -$359.0 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | 1.48 Bn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | 159.00 Mn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | 137.00 Mn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | -315.00 Mn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | -176.00 Mn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | 179.00 Mn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | -12.00 Mn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | 161.00 Mn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 161.00 Mn |
| Dec 31, 2025 | -392.00 Mn |
| Sep 30, 2025 | -359.00 Mn |
| Jun 30, 2025 | -437.00 Mn |
| Mar 31, 2025 | 223.00 Mn |
| Dec 31, 2024 | -791.00 Mn |
| Sep 30, 2024 | -256.00 Mn |
| Jun 30, 2024 | -331.00 Mn |
| Mar 31, 2024 | -711.00 Mn |
| Dec 31, 2023 | -1.33 Bn |
| Sep 30, 2023 | -327.00 Mn |
| Jun 30, 2023 | -1.09 Bn |
| Mar 31, 2023 | -548.00 Mn |
| Dec 31, 2022 | -624.00 Mn |
| Sep 30, 2022 | -645.00 Mn |
| Jun 30, 2022 | -782.00 Mn |
| Mar 31, 2022 | -687.00 Mn |
| Dec 31, 2021 | -1.27 Bn |
| Sep 30, 2021 | -32.00 Mn |
| Jun 30, 2021 | -163.00 Mn |
| Mar 31, 2021 | 68.00 Mn |
| Dec 31, 2020 | -436.00 Mn |
| Sep 30, 2020 | 853.00 Mn |
| Jun 30, 2020 | 853.00 Mn |
| Mar 31, 2020 | -53.00 Mn |
| Dec 31, 2019 | -388.00 Mn |
| Sep 30, 2019 | -423.00 Mn |
| Jun 30, 2019 | -191.00 Mn |
| Mar 31, 2019 | 78.00 Mn |
| Dec 31, 2018 | 206.00 Mn |
| Sep 30, 2018 | -124.00 Mn |
| Jun 30, 2018 | -197.00 Mn |
| Mar 31, 2018 | 160.00 Mn |
| Dec 31, 2017 | 170.00 Mn |
| Sep 30, 2017 | 262.00 Mn |
| Jun 30, 2017 | 91.00 Mn |
| Mar 31, 2017 | -70.00 Mn |
| Dec 31, 2016 | 296.00 Mn |
| Sep 30, 2016 | -183.00 Mn |
| Jun 30, 2016 | -71.00 Mn |
| Mar 31, 2016 | -246.00 Mn |
| Dec 31, 2015 | -398.00 Mn |
| Sep 30, 2015 | 110.00 Mn |
| Jun 30, 2015 | -52.00 Mn |
| Mar 31, 2015 | -7.00 Mn |
| Dec 31, 2014 | -485.00 Mn |
| Sep 30, 2014 | -93.00 Mn |
| Jun 30, 2014 | -74.00 Mn |
| Mar 31, 2014 | 110.00 Mn |
| Dec 31, 2013 | -82.00 Mn |
| Sep 30, 2013 | -74.00 Mn |
| Jun 30, 2013 | -153.00 Mn |
| Mar 31, 2013 | -182.00 Mn |
| Dec 31, 2012 | -493.00 Mn |
| Sep 30, 2012 | -817.00 Mn |
| Jun 30, 2012 | -124.00 Mn |
| Mar 31, 2012 | 204.00 Mn |
| Dec 31, 2011 | 142.00 Mn |
| Sep 30, 2011 | 30.00 Mn |
| Jun 30, 2011 | 66.00 Mn |
| Mar 31, 2011 | 177.00 Mn |
| Dec 31, 2010 | 322.00 Mn |
| Sep 30, 2010 | 3.00 Mn |
| Jun 30, 2010 | 7.00 Mn |
| Mar 31, 2010 | 90.00 Mn |
| Dec 31, 2009 | -16.00 Mn |
| Sep 30, 2009 | 67.00 Mn |